Example: tourism industry

EMPA-REG- CV Outcomes Trial Summary - RxFiles

RXFILES TRIAL SUMMARY .R . APR 2016 – WWW XFILES CA Page 1 of 3 EMPA-REG: CV Outcomes Trial Summary Empagliflozin: Cardiovascular (CV) Outcomes and Mortality in Patients with Type 2 Diabetes Mellitus (T2DM) In patients with T2DM and at high risk of CV events, does empagliflozin reduce CV risk compared to placebo when added to standard care?

Tags:

  Summary, Trail, Rxfiles, Rxfiles trial summary, Trial summary

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of EMPA-REG- CV Outcomes Trial Summary - RxFiles